Claraphi Advisory Network, LLC Syros Pharmaceuticals, Inc. Transaction History

Claraphi Advisory Network, LLC

  • $248 Million
  • Q4 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 12, 2019
SELL
$5.55 - $11.34 $99,900 - $204,120
-18,000 Closed
0 $0
Q3 2018

Nov 09, 2018
BUY
$9.74 - $12.92 $19,480 - $25,840
2,000 Added 12.5%
18,000 $214,000
Q2 2018

Aug 14, 2018
BUY
$10.16 - $13.65 $162,560 - $218,400
16,000 New
16,000 $163,000

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $43.1M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Claraphi Advisory Network, LLC Portfolio

Follow Claraphi Advisory Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Claraphi Advisory Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Claraphi Advisory Network, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email